Trials / Unknown
UnknownNCT02142166
The Role of Biomarker in Serum, Cerebrospinal Fluid and Parenchyma in the Context of Aneurysmal Subarachnoid Hemorrhage.
Die Rolle Der Biomarker in Serum, Liquor Und Parenchym im Rahmen Der Aneurysmatischen Subarachnoidalblutung: Verlauf Und Korrelation zu Therapie Und Outcome - bioSAB -
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 310 (estimated)
- Sponsor
- RWTH Aachen University · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to improve the usability of biomarkers for the timely prediction of new complications following a cerebral hemorrhage, especially in combination with invasive, functional and local measurements for patients with aneurysmal subarachnoid hemorrhage (SAH). Based on analyzed biomarker profiles the chosen therapy efforts are assessed in their immediate and longer-term effectiveness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Biomarker in serum, liquor, micro-dialysate | Daily (21 days) analysis of biomarker in serum, in liquor and in micro-dialysate |
| PROCEDURE | Biomarker in serum and in liquor | Single analysis of biomarker in serum and liquor |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2020-12-01
- Completion
- 2020-12-01
- First posted
- 2014-05-20
- Last updated
- 2020-02-05
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02142166. Inclusion in this directory is not an endorsement.